Abhay Joshi

2020

In 2020, Abhay Joshi earned a total compensation of $4.1M as Chief Operating Officer at Revance Therapeutics, a 113% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$213,726
Option Awards$1,913,759
Salary$514,608
Stock Awards$1,405,850
Other$11,731
Total$4,059,674

Joshi received $1.9M in option awards, accounting for 47% of the total pay in 2020.

Joshi also received $213.7K in non-equity incentive plan, $514.6K in salary, $1.4M in stock awards and $11.7K in other compensation.

Rankings

In 2020, Abhay Joshi's compensation ranked 2,809th out of 13,090 executives tracked by ExecPay. In other words, Joshi earned more than 78.5% of executives.

ClassificationRankingPercentile
All
2,809
out of 13,090
79th
Division
Manufacturing
1,073
out of 5,620
81st
Major group
Chemicals And Allied Products
400
out of 2,253
82nd
Industry group
Drugs
345
out of 1,953
82nd
Industry
Pharmaceutical Preparations
252
out of 1,458
83rd

Pay ratio

Abhay Joshi's Pay$4,059,674
Median Employee's Pay$254,090
Pay Ratio

16

to 1

In 2020, the annual total compensation of Abhay Joshi was $4,059,674.

The annual total compensation of the median employee at Revance Therapeutics was $254,090.

The ratio of Abhay Joshi's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on March 24, 2021.

Joshi's colleagues

We found four more compensation records of executives who worked with Abhay Joshi at Revance Therapeutics in 2020.

2020

Mark Foley

Revance Therapeutics

Chief Executive Officer

2020

Dwight Moxie

Revance Therapeutics

General Counsel

2020

Dustin Sjuts

Revance Therapeutics

Chief Commercial Officer

2020

Tobin Schilke

Revance Therapeutics

Chief Financial Officer

News

You may also like